Lugano, Switzerland, 25 July 2014. The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General… read more.
by Esther Drain – Skin cancer is now the commonest cancer in the UK and the incidence is rising, mainly due to people taking more holidays in sunny… read more.
Report from the British Association of Dermatologists Conference, held in Glasgow, 30th June -3rd July 2014 by Christine Clark. The use of antibiotics for acne could be phased… read more.
Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials. ‘The company should be encouraged by the drug’s demonstrated efficacy in mild… read more.
by Bruce Sylvester – 3D Mammography detects a significantly higher rate of invasive cancers and reduces the rate of unnecessary recalls, researchers reported on June 25, 2014 in… read more.
by Bruce Sylvester – Findings published on June 4 in the New England Journal of Medicine show that the antibiotic dalbavancin is as effective as vancomycin for treating serious bacterial… read more.
by Bruce Sylvester – Elevated systolic and diastolic blood pressure appear to be predictive of different cardiovascular diseases and at different ages, researchers reported in a special themed… read more.
by Bruce Sylvester – Heart attack survivors appear to live longer by increasing dietary intake of fiber, and consumption of increased cereal fiber is especially beneficial, researchers reported… read more.
by Bruce Sylvester – Treatment with tadalafil or sidenafil appears to improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to research published in… read more.
by Bruce Sylvester – Adding goserelin to standard chemotherapy significantly reduces the risk of early menopause in breast cancer patients, researchers reported in May of 2014 at the… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
by Bruce Sylvester – The selective serotonin reuptake inhibitor (SSRI) citalopram appears to impede development of amyloid beta, a plaque-forming peptide in the brain believed to be involved… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
